Delivery Order SPE2DB20D1004-SPE2DB22FG1D6

Award Date 8/30/22
Potential Completion Date 8/31/22
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $7,678.86 and is a Firm Fixed Price (FFP) contract type. It does not have a set-aside designation. The ultimate completion date for this delivery order is September 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4560683499 LIDOCAINE 5% PATCH 30S. The contract has a firm fixed price of $14,279.13 and a completion date of April 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,150.56, is for the supply of 4565617850 LIDOCAINE 5% PATCH 30S, a prescription medication. The order has an ultimate completion date of August 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a $1,701.30 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIDOCAINE 5% PATCH 30S, a medical product, with a period of performance ending on February 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,151.80 award is for the delivery of 4565215226 - LIDOCAINE 5% PATCH 30S, with a period of performance through July 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The delivery order, valued at $2,561.14, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This IDC enables the DLA to efficiently procure a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The order has a ceiling value of $7,156.65 and an ultimate completion date of October 24, 2022. It is a firm fixed-price contract under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999.00 through December 2025. This IDC serves as the...
This is a $1,109.75 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA) for the supply of 4565735143 - LIDOCAINE 5% PATCH 30S. The delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $2,991.25 and runs through January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $4,006.77 firm-fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a medical product used to treat pain. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen has been awarded this contract as a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FG1D6
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $3,687.84 and an ultimate completion date of August 31, 2022. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not specify any set-aside requirements, indicating open competition. This delivery order is part of the broader DLA procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:58 AM